BCRX

SEC source: 0001127602-24-018725 · form4.xml · derivative · entry 2

LEVIN ALAN G · CIK 0001174452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F2 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018725 · form4.xml · nonDerivative · entry 1

LEVIN ALAN G · CIK 0001174452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,771

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

SEC source: 0001127602-24-018720 · form4.xml · derivative · entry 2

Hutson Nancy J · CIK 0001379222 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F2 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018720 · form4.xml · nonDerivative · entry 1

Hutson Nancy J · CIK 0001379222 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,638

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

SEC source: 0001127602-24-018715 · form4.xml · derivative · entry 3

HEGGIE THERESA · CIK 0001760020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F4 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018715 · form4.xml · nonDerivative · entry 1

HEGGIE THERESA · CIK 0001760020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,550

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

SEC source: 0001127602-24-018711 · form4.xml · derivative · entry 3

Galson Steven K · CIK 0001495328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F3 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018711 · form4.xml · nonDerivative · entry 1

Galson Steven K · CIK 0001495328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,431

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

F2 · balance_after: The shares purchased by the reporting person on May 13, 2024 were inadvertently reported as being purchased directly by the reporting person but were actually purchased by the reporting person's trust. The reporting person is a trustee of such trust and the reporting person and members of his family are the sole beneficiaries of the trust. The reporting person is an indirect beneficial owner of the shares held by the trust.

SEC source: 0001127602-24-018705 · form4.xml · derivative · entry 2

ABERCROMBIE GEORGE B · CIK 0001485939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F2 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018705 · form4.xml · nonDerivative · entry 1

ABERCROMBIE GEORGE B · CIK 0001485939 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,431

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

SEC source: 0001127602-24-018708 · form4.xml · derivative · entry 3

ASELAGE STEVE · CIK 0001221599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,933

Underlying: Common Stock · 49,933 shares

Expires 2034-06-12

F2 · security: Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

SEC source: 0001127602-24-018708 · form4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,159

F1 · shares: Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.

SEC source: 0001127602-24-017295 · form4.xml · nonDerivative · entry 1

MILANO VINCENT · CIK 0001187159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,867

F1 · shares: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

SEC source: 0001127602-24-017302 · form4.xml · nonDerivative · entry 1

HEGGIE THERESA · CIK 0001760020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,730

F1 · shares: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

SEC source: 0001127602-24-017121 · form4.xml · nonDerivative · entry 1

LEVIN ALAN G · CIK 0001174452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,951

SEC source: 0001127602-24-016776 · form4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,500

SEC source: 0001127602-24-016190 · form4.xml · nonDerivative · entry 1

Hutson Nancy J · CIK 0001379222 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,818

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $6.375 to $6.38. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-016188 · form4.xml · nonDerivative · entry 1

MILANO VINCENT · CIK 0001187159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,997

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $6.23 to $6.25. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-015373 · form4.xml · nonDerivative · entry 1

Doyle Anthony · CIK 0001808688 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 266,744

SEC source: 0001127602-24-015371 · form4.xml · nonDerivative · entry 1

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,139

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.84 to $5.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-015369 · form4.xml · nonDerivative · entry 1

Galson Steven K · CIK 0001495328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,551

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.48 to $5.49. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-015367 · form4.xml · nonDerivative · entry 1

Barnes Alane P · CIK 0001584348 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,762

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.36 to $5.64. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-015363 · form4.xml · nonDerivative · entry 1

Gayer Charles K · CIK 0001800110 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,533

SEC source: 0001127602-24-015365 · form4.xml · nonDerivative · entry 1

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,127,770

F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.34 to $5.68. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0001127602-24-011832 · form4.xml · nonDerivative · entry 1

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,139

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-24-008156 · form4.xml · nonDerivative · entry 1

MILANO VINCENT · CIK 0001187159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,997

F1 · shares: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

SEC source: 0001127602-24-008140 · form4.xml · nonDerivative · entry 1

HEGGIE THERESA · CIK 0001760020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,860

F1 · shares: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

SEC source: 0001127602-24-000832 · form4.xml · nonDerivative · entry 3

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust

Disclosed balance after: 20,000

F1 · kind: On January 3, 2024, the reporting person gifted 10,000 shares held directly by him to each of the Samuel Stonehouse Irrevocable Trust and the Caroline Stonehouse Irrevocable Trust.

SEC source: 0001127602-24-000832 · form4.xml · nonDerivative · entry 2

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust

Disclosed balance after: 20,000

F1 · kind: On January 3, 2024, the reporting person gifted 10,000 shares held directly by him to each of the Samuel Stonehouse Irrevocable Trust and the Caroline Stonehouse Irrevocable Trust.

SEC source: 0001127602-24-000832 · form4.xml · nonDerivative · entry 1

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,094,770

F1 · kind: On January 3, 2024, the reporting person gifted 10,000 shares held directly by him to each of the Samuel Stonehouse Irrevocable Trust and the Caroline Stonehouse Irrevocable Trust.

SEC source: 0001127602-23-030189 · form4.xml · nonDerivative · entry 1

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,664

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-030187 · form4.xml · nonDerivative · entry 1

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,114,770

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-030181 · form4.xml · nonDerivative · entry 1

Doyle Anthony · CIK 0001808688 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,444

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-030185 · form4.xml · nonDerivative · entry 1

Gayer Charles K · CIK 0001800110 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,533

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-030177 · form4.xml · nonDerivative · entry 1

Barnes Alane P · CIK 0001584348 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,539

F1 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029839 · form4.xml · derivative · entry 3

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,000

Underlying: Common Stock · 238,000 shares

Expires 2033-12-14

F3 · derivative.exercise_date: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029839 · form4.xml · nonDerivative · entry 2

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,244

F2 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029839 · form4.xml · nonDerivative · entry 1

Thackray Helen M. · CIK 0001589725 · Chief R&D Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,275

F1 · shares: Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029835 · form4.xml · derivative · entry 5

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 595,000

Underlying: Common Stock · 595,000 shares

Expires 2033-12-14

F3 · derivative.exercise_date: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029835 · form4.xml · nonDerivative · entry 4

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,128,859

F2 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029835 · form4.xml · nonDerivative · entry 3

Stonehouse Jon P · CIK 0001385496 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,142,451

F1 · shares: Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029833 · form4.xml · derivative · entry 3

Gayer Charles K · CIK 0001800110 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,500

Underlying: Common Stock · 158,500 shares

Expires 2033-12-14

F3 · derivative.exercise_date: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029833 · form4.xml · nonDerivative · entry 2

Gayer Charles K · CIK 0001800110 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,015

F2 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029833 · form4.xml · nonDerivative · entry 1

Gayer Charles K · CIK 0001800110 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,855

F1 · shares: Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029831 · form4.xml · derivative · entry 3

Doyle Anthony · CIK 0001808688 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,500

Underlying: Common Stock · 158,500 shares

Expires 2033-12-14

F3 · derivative.exercise_date: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029831 · form4.xml · nonDerivative · entry 2

Doyle Anthony · CIK 0001808688 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,926

F2 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029831 · form4.xml · nonDerivative · entry 1

Doyle Anthony · CIK 0001808688 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,401

F1 · shares: Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029829 · form4.xml · derivative · entry 3

Barnes Alane P · CIK 0001584348 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,500

Underlying: Common Stock · 158,500 shares

Expires 2033-12-14

F3 · derivative.exercise_date: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001127602-23-029829 · form4.xml · nonDerivative · entry 2

Barnes Alane P · CIK 0001584348 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,021

F2 · shares: Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

SEC source: 0001127602-23-029829 · form4.xml · nonDerivative · entry 1

Barnes Alane P · CIK 0001584348 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,036

F1 · shares: Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.